NZ703020A - Method for preparing substituted triazolopyridines - Google Patents

Method for preparing substituted triazolopyridines

Info

Publication number
NZ703020A
NZ703020A NZ703020A NZ70302013A NZ703020A NZ 703020 A NZ703020 A NZ 703020A NZ 703020 A NZ703020 A NZ 703020A NZ 70302013 A NZ70302013 A NZ 70302013A NZ 703020 A NZ703020 A NZ 703020A
Authority
NZ
New Zealand
Prior art keywords
preparing substituted
substituted triazolopyridines
compounds
triazolopyridines
preparing
Prior art date
Application number
NZ703020A
Other languages
English (en)
Inventor
Volker Schulze
Franz-Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of NZ703020A publication Critical patent/NZ703020A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ703020A 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines NZ703020A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
NZ703020A true NZ703020A (en) 2017-08-25

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ703020A NZ703020A (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Country Status (24)

Country Link
US (1) US9388177B2 (instruction)
EP (1) EP2872506A1 (instruction)
JP (1) JP6238979B2 (instruction)
KR (1) KR20150040845A (instruction)
CN (1) CN104603136B (instruction)
AP (1) AP3778A (instruction)
AU (1) AU2013289381A1 (instruction)
BR (1) BR112015000308A2 (instruction)
CA (1) CA2878481A1 (instruction)
CL (1) CL2015000038A1 (instruction)
CO (1) CO7160002A2 (instruction)
CR (1) CR20150006A (instruction)
DO (1) DOP2015000007A (instruction)
EA (1) EA027544B1 (instruction)
HK (1) HK1206731A1 (instruction)
IL (1) IL236265A (instruction)
IN (1) IN2015DN00085A (instruction)
MX (1) MX2015000348A (instruction)
NZ (1) NZ703020A (instruction)
PE (1) PE20150354A1 (instruction)
PH (1) PH12015500061A1 (instruction)
SG (1) SG11201408419QA (instruction)
TN (1) TN2015000008A1 (instruction)
WO (1) WO2014009219A1 (instruction)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195276A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
ES2626790T3 (es) * 2013-06-11 2017-07-26 Bayer Pharma Aktiengesellschaft Derivados de profármacos de triazlopiridinas sustituidas
JP2016520665A (ja) 2013-06-11 2016-07-14 バイエル・ファルマ・アクティエンゲゼルシャフト Mps−1キナーゼ阻害剤および有糸分裂阻害剤を含む、癌の治療のための組合わせ
DK3283642T3 (da) 2015-04-17 2024-01-02 Crossfire Oncology Holding B V Prognostiske biomarkører til ttk-hæmmerbaseret kemoterapi
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009812A1 (en) * 2001-10-05 2005-01-13 Takuya Seko Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
WO2005110410A2 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
MX2007004179A (es) * 2004-10-07 2007-06-07 Warner Lambert Co Derivados de triazolpiridina como agentes antibacterianos.
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
WO2007145921A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
ES2549862T3 (es) 2006-08-30 2015-11-02 Cellzome Limited Derivados de triazol como inhibidores de quinasa
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JP2010533680A (ja) 2007-07-18 2010-10-28 ノバルティス アーゲー 二環ヘテロアリール化合物およびそれらのキナーゼ阻害剤としての使用
CN103298814A (zh) 2007-08-23 2013-09-11 阿斯利康(瑞典)有限公司 作为治疗增殖性疾病的ttk/mps1抑制剂的2-苯胺基嘌呤-8-酮
US8263595B2 (en) 2007-08-31 2012-09-11 Merck Serono Sa Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
WO2009155527A2 (en) * 2008-06-19 2009-12-23 Progenics Pharmaceuticals, Inc. Phosphatidylinositol 3 kinase inhibitors
BRPI1008850A2 (pt) 2009-02-13 2016-03-15 Fovea Pharmaceuticals [1,2,4]triazolo[1,5-a]piridinas como inibidores de quinase
ES2547328T3 (es) 2009-04-29 2015-10-05 Bayer Intellectual Property Gmbh Imidazoquinoxalinas sustituidas
AU2010254806C1 (en) * 2009-06-05 2016-07-07 Cephalon, Inc. Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
JP5728683B2 (ja) 2009-09-04 2015-06-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
EP2343295A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
WO2012143329A1 (en) * 2011-04-21 2012-10-26 Bayer Intellectual Property Gmbh Triazolopyridines
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
JP2015523372A (ja) 2015-08-13
CA2878481A1 (en) 2014-01-16
MX2015000348A (es) 2015-04-14
CR20150006A (es) 2015-02-16
EA201590116A1 (ru) 2015-07-30
AP2014008177A0 (en) 2014-12-31
AP3778A (en) 2016-08-31
KR20150040845A (ko) 2015-04-15
JP6238979B2 (ja) 2017-11-29
CN104603136A (zh) 2015-05-06
IL236265A0 (en) 2015-02-26
US20150148542A1 (en) 2015-05-28
CN104603136B (zh) 2017-06-27
BR112015000308A2 (pt) 2017-06-27
IL236265A (en) 2017-07-31
CL2015000038A1 (es) 2015-03-13
SG11201408419QA (en) 2015-01-29
US9388177B2 (en) 2016-07-12
PH12015500061A1 (en) 2015-03-02
TN2015000008A1 (en) 2016-06-29
AU2013289381A1 (en) 2015-01-22
EA027544B1 (ru) 2017-08-31
CO7160002A2 (es) 2015-01-15
WO2014009219A1 (en) 2014-01-16
DOP2015000007A (es) 2015-02-15
HK1206731A1 (en) 2016-01-15
EP2872506A1 (en) 2015-05-20
PE20150354A1 (es) 2015-03-21
IN2015DN00085A (instruction) 2015-05-29

Similar Documents

Publication Publication Date Title
AU2012213775A8 (en) 7-azaindole derivatives
MD20150091A2 (ro) Compuşi antivirali
UA111186C2 (uk) Способи та композиції для одержання норибогаїну з воакангіну
MX360499B (es) Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas.
MY167697A (en) Method for producing 4,4-difluoro-3,4- dihydroisoquinoline derivatives
PH12014501258A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
EP2894160A4 (en) NOVEL COMPOUNDS WITH THROMBOLYE EFFECT, DETECTION OF FREE RADICAL AND THROMBUS TARGETING, AND METHOD FOR THEIR PREPARATION AND USE
MX375872B (es) Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas.
EA201590887A1 (ru) Композиция
PH12013502169A1 (en) Triazolopyridines
IN2015KN00323A (instruction)
GEP201706690B (en) Novel process for making compounds for use in treatment of cancer
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GEP201706626B (en) Synthesis of (s)-nifuratel
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
GB201107985D0 (en) Process
IN2014DN09451A (instruction)
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
WO2013072938A3 (en) Process for the preparation of roflumilast
PH12015500527A1 (en) Macrolide derivatives, preparation and therapeutic use thereof
IN2014DN10135A (instruction)
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
IN2014DN07407A (instruction)
PH12015502703A1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed